BMP2及Msx2在特发性高钙尿肾结石患者肾乳头组织表达的研究

何登; 王少刚; 唐锦辉; 贾招晖; 郭丙涛; 黄雷

BMP2及Msx2在特发性高钙尿肾结石患者肾乳头组织表达的研究

- 1. 华中科技大学同济医学院附属同济医院泌尿外科(武汉, 430030);
- 2. 华中科技大学同济医学院附属同济医院儿科
基金项目:
国家自然科学基金资助项目（编号30972985）

详细信息

通讯作者: 唐锦辉,E-mail:jinhuitang@tjh.tjmu.edu.cn

中图分类号: R696

收稿日期: 2012-09-27

Expression of osteoblast-like cell transcription factors BMP2, Msx2 in renalpapillary of idiopathic hypercalciuria patients with renal calculus and implications

- 1. Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China;
- 2. Department of Paediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

More Information

Corresponding author: TANG Jinhui, E-mail: jinhuitang@tjh.tjmu.edu.cn

Received Date: 27 September 2012

摘要

摘要: 目的：研究骨形态发生蛋白2（BMP2）及成骨样细胞转录因子Msx2在特发性高钙尿（IH）肾结石患者肾乳头组织中表达以及探讨其在IH患者结石形成中作用机制。方法：筛选特发性高钙尿肾结石患者8例（IH组），排除各种已知可能影响血清钙或者尿钙的继发疾病；选择同期因肾肿瘤或非结石所致的无功能肾需行肾切除术的患者8例（NC组）。分别取16例患者肾乳头组织若干，各标本应用实时荧光定量PCR检测BMP2和Msx2 mRNA的表达，并应用Western blot测定两组蛋白质表达水平。结果：IH组BMP2的mRNA表达量为（1.491±0.121），而NC组BMP2的mRNA为（1.032±0.034），两组间表达量差异有统计学意义（P<0.05）；而IH组与NC组Msx2的mRNA表达量分别为（1.432±0.091）和（1.015±0.017），两组数据差异有统计学意义（P<0.05）。Western blotting检测BMP2蛋白提示NC组和IH组蛋白质表达量分别为（1.475±0.042）和（1.681±0.153），两组数据差异有统计学意义（P<0.05）；测定Msx2蛋白水平表达显示NC组为（1.531±0.134），而IH组（1.603±0.156），两者差异无统计学意义（P>0.05）。结论：特发性高钙尿（IH）肾结石患者肾乳头BMP2和Msx2 mRNA表达增强为间质异位钙化特征，BMP2信号通路在特发性高钙尿结石患者Randall钙斑形成中具有一定作用。
- 特发性高钙尿 /
- 骨形态发生蛋白2 /
- 成骨样细胞转录因子 /
- Msx2
Abstract: Objective: To explore the abnormal expression of Bone morphogenetic protein2 and mosteoblast-like cell transcription factors Msx2 in idiopathic hypercalciuria (IH) patients with renal calculus and their effect on pathogenesis of stone formation in IH.Method: Eight patients with idiopathic hypercalciuria and calculus (IH group) were taken, and excluding all known secondary disease that could affect serum calcium or urinary calcium.To set a control, 8 patients need to be taken nephrectomy because of renal carcinoma or non-functioning kidney precluding the cause of kidney stones (NC group). 16 patients were taken certain renal papillary tissue under reasonable conditions. Real-time quantitative PCR and Western blot were used to detect the protein and gene expression levels of BMP2 and Msx2.Result: The mRNA expression of BMP2 in IH group was (1.491±0.121), while BMP2 expression in the NC group was (1.032±0.034), and expression values between the two groups was statistically significant (P<0.05); the mRNA levels of Msx2 in IH group and NC group were (1.432±0.091), (1.015±0.017), respectively, and the two sets of data were significantly different (P<0.05).BMP2 protein detected by Western blotting prompted that the NC group and IH group were (1.475±0.042) and (1.681±0.153), respectively, these was statistically significant difference between two groups, P<0.05. Msx2 protein expression showed that the NC group was (1.531±0.134), while the IH group was (1.603±0.156), the difference was not statistically significant, P>0.05.Conclusion: Overexpression of BMP2 and Msx2 mRNA in renal papillary of Idiopathic hypercalciuria (IH) patients with kidney stones indicates that it exists certain mechanism which have related to interstitial ectopic calcification, and BMP2 signaling pathway have an effect on Randall's plaque formation in renal idiopathic calcium oxalate stones patients.
- idiopathic hypercalciuria /
- BMP2 /
- osteoblast-like cell transcription factors /
- Msx2

HTML全文

参考文献(16)

[1]	Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis[J]. Kidney Int, 2009, 75:585-595.
[2]	Ryall R L. The future of stone research:rummagings in the attic, Randall's plaque, nanobacteria, and lessons from phylogeny[J]. Urol Res, 2008, 36:77-97.
[3]	胡东亮, 王少刚, 叶章群. TRPV5与特发性高钙尿症的研究进展[J]. 现代泌尿外科杂志, 2008, 13(4):328-330.
[4]	王少刚, 苏世强, 席启林, 等. 遗传性高钙尿结石大鼠肾小管上皮细胞基底膜钙转运蛋白的异常表达及意义[J]. 中华实验外科杂志, 2008, 25(9):1178-1180.
[5]	Wu-Wong J R, Melnick J. Vascular calcification in chronic kidney failure:role of vitamin D receptor[J]. Curr Opin Investig Drugs, 2007, 8:237-247.
[6]	Hruska K A, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification[J]. Circ Res, 2005, 97:105-114.
[7]	Shao J S, Cai J, Towler D A. Molecular mechanisms of vascular calcification:lessons learned from the aorta[J]. Arterioscler Thromb Vasc Biol, 2006, 26:1423-1430.
[8]	Matsubara T, Kida K, Yamaguchi A, et al. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation[J]. J Biol Chem, 2008, 283:29119-29125.
[9]	Boström K, Watson KE, Horn S, et al. Bone morphogenetic protein expression in human atherosclerotic lesions[J]. J Clin Invest, 1993, 91:1800-1809.
[10]	Zebboudj A F, Imura M, Boström K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2[J]. J Biol Chem, 2002, 277:4388-4394.
[11]	Gao B, Yasui T, Itoh Y, et al. A polymorphism of matrix Gla protein gene is associated with kidney stones[J]. J Urol, 2007, 177:2361-2365.
[12]	Jeon E J, Lee K Y, Choi N S, et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation[J]. J Biol Chem, 2006, 281:16502-16511.
[13]	Alexopoulos A, Bravou V, Peroukides S, et al. Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves[J]. Int J Cardiol, 2010, 139:142-149.
[14]	Gao Y, Jheon A, Nourkeyhani H, et al. Molecular cloning, structure, expression, and chromosomal localization of the human Osterix (SP7) gene[J]. Gene, 2004, 341:101-110.
[15]	Ulsamer A, Ortuño M J, Ruiz S, et al. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38[J]. J Biol Chem, 2008, 283:3816-3826.
[16]	Hruska K A, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification[J]. Circ Res, 2005, 97:105-114.